NL-OMON55717已完成不适用
Pulmonary artERial hypertenSion: bonE morPHOgeNEtic protein signaling out of control (PERSEPHONE) - PERSEPHONE
VU medisch centrum0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •Aim 1: BMP10 secretion by right atrial cardiomyocytes
- •Inclusion criteria patients:
- •- Patients with chronic thrombo-embolic pulmonary hypertension (CTEPH)
- •- Undergoing pulmonary endarterectomy, Inclusion criteria controls:
- •- Patients undergoing cardiac surgery and put on the heart-lung machine, Aim 2:
- •BMP10 release as a bio-assay of right heart failure, Inclusion criteria
- •- Idiopathic PAH (Invasively assessed mean pulmonary artery pressure >25 mmHg,
- •pulmonary artery wedge pressure <15 mmHg)
- •- Right heart catheterization and magnetic resonance imaging < 1 year before
- •participation
- •- Age > 18 years, Inclusion criteria controls:
- •- Age >18 years
- •- Age and sex-matched to patients
- •- We will include 10 subjects with a BMPR2 mutation without Pulmonary
- •Hypertension
排除标准
- •Aim 1: BMP10 secretion by right atrial cardiomyocytes, Exclusion criteria
- •- Age < 18 years, Exclusion criteria controls:
- •- Pulmonary hypertension (according to European Society of Cardiology
- •guidelines: echocardiography, tricuspid regurgitation peak velocity * 2.8
- •m/sec, estimated systolic pulmonary artery pressure * 36 mmHg and no additional
- •echocardiographic signs of pulmonary hypertension)(13)
- •- RV dysfunction (TAPSE < 16 mm)(13)
- •- RV (annulus) dilatation (RV end-diastolic diameter > 42 mm (base))(13)
- •- Tricuspid valve replacement or tricuspid annuloplasty
- •- Dilated right atrium or RA dysfunction (e.g. related to atrial fibrillation,
- •congenital abnormalities; cut-off values: area > 18 cm2)
- •- Age < 18 years, Aim 2: BMP10 release as a bio-assay of right heart failure,
- •Exclusion criteria patients:
- •- Pregnancy
- •- Claustrophobia
- •- Pacemaker, Exclusion criteria controls:
- •- Pulmonary hypertension (Invasively assessed mean pulmonary artery pressure >
- •- Increased pulmonary artery wedge pressure (>15 mmHg)
- •- Tricuspid valve dysfunction
- •- RV dysfunction
- •- Dilated right atrium or RA dysfunction (e.g. related to atrial fibrillation,
- •congenital abnormalities)
- •- Previous cardiac surgery
- •- Age < 18 years
研究者
相似试验
已完成
不适用
Investigation of mechanisms of pulmonary hypertension due to left heart diseaseHeart Failurepulmonary hypertensionJPRN-jRCTs041180123Dohi Kaoru100
已完成
不适用
Investigation of mechanisms of pulmonary hypertension due to left heart diseaseJPRN-UMIN000025460DH-PH study Project Office100
尚未招募
Unknown
Pulmonary Hypertension in Connective Tissue DisordersCTRI/2024/03/063822Aditi Rao
尚未招募
Unknown
Clinical Profile of Persistent Pulmonary Hypertension Of Newborn in AVBRHCTRI/2024/01/061934ONE
已完成
不适用
Investigation of pulmonary hypertension in patients receiving tyrosine kinase inhibitorsChronic myelogenous leukemia, Philadelphia chromosome-positive acute lymphoblastic leukemiaJPRN-UMIN000016857Kyushu university100
